Why NovaSom?

NovaSom is a leader in obstructive sleep apnea home testing with the AccuSom® home sleep test, a comprehensively supported home sleep test that provides continuous patient support and next-day test results and interpretation for health care professionals. The FDA-cleared AccuSom test is significantly more convenient and comfortable for patients, compared to in-facility testing. Patients are able to test around their own schedule and can sleep in their own bed, which helps eliminate “first night” effect and improves data collection. AccuSom is currently covered for more than 150 million commercially insured U.S. lives. NovaSom is accredited by the Joint Commission as an Ambulatory Care Sleep Diagnostic Center & Telehealth Provider and is classified by CMS as an Independent Diagnostic Testing Facility.

Market Opportunity

The OSA diagnostic market in the U.S. is estimated to be approximately $4 billion and is growing more than 15% annually. Only 3 million sufferers in the U.S. have been diagnosed to date, out of an estimated 40 million moderate to severe OSA sufferers.

(Visited 976 times, 1 visits today)

Company Milestones

  • Founded as Sleep Solutions, Inc.
  • Sleep Solutions, Inc. re-incorporates as NovaSom, Inc.
  • NovaSom partners with HealthAmerica to launch an innovative sleep management plan
  • NovaSom appoints Dr. Michael Coppola as Chief Medical Officer
  • NovaSom launches to highlight health consequences of undiagnosed sleep apnea
  • NovaSom launches AccuSom Deliver™ program for out-of-center sleep testing (OCST)
  • NovaSom announces the launch of AccuSom Safe Recovery™ for anesthesiologists
  • NovaSom appoints John Spitznagel as CEO

Home sleep test that provides continuous patient assistance and next-day test results and interpretation.